Detail page

Knowledge Web

Person

Michael Kreuter (1972-)

Internist

Name	Michael Kreuter
Time	1972- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Prof. Dr. med.
Profession	Internist (characteristic profession) Pneumologe
Variant	Michael Helmut Kreuter
Related	Universitätsmedizin Mainz (03/2023-) Thoraxklinik Heidelberg (07/2005-02/2023) Universität Heidelberg. Medizinische Fakultät (08/2015-)
Further information	W3-Professur für Innere Medizin mit Schwerpunkt Pneumologie ab 1. Juli 2024 und leitet gemeinsam mit Herrn Univ.-Prof. Dr. Eric Rößner (Thoraxchirurgie) das Zentrum für Thoraxerkrankungen Unimedizin Mainz; Diss. Fachbereich Humanmedizin; Oberarzt Innere Medizin/Pneumologie, Thoraxklinik, Universitätsklinikum Heidelberg
Source	Homepage der Thoraxklinik: https://www.thoraxklinik-heidelberg.de/index.php?id=252 (Stand: 06.05.2020)
Record type	Person
GND-Identifier	122645995
Record ID	122645995
Involved in show all Osteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study National survey on the presence of multidisciplinary meetings for interstitial lung diseases (ILD-MDM) in hospitals in Germany Nationale Umfrage zur Präsenz von interdisziplinären Fallkonferenzen bei interstitiellen Lungenerkrankungen (ILD-Boards) an Kliniken in Deutschland Image analysis: 68Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology SARS-CoV-2 Vaccination in Primary Humoral Immunodeficiency: Experience from a German Lung Clinic Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort Real-life characteristics and management of patients with fibrosing interstitial lung disease Xolair-Dosisreduktion bei Patienten mit schwerem allergischen Asthma bronchiale in der Dauertherapie Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional survey Situation der Betreuung von Lungenkarzinompatienten im Hinblick auf Mindestmengenregelung und Personalmangel Is YouTube a sufficient source of information on Sarcoidosis? Diagnostik und Therapie der exogen-allergischen Alveolitis : S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Gesellschaft für Allergologie und klinische Immunologie e. V. Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry miR-Blood – a small RNA atlas of human blood components Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory Society YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) Impact of systemic Sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival : : a large cohort study of the German network for systemic Sclerosis Interstitielle Lungenerkrankungen : Klassifikation, Differenzialdiagnostik und therapeutische Ansätze bei einer heterogenen Gruppe chronischer Lungenerkrankungen Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial Fieber, Husten, Gliederschmerzen - ein banaler Infekt? Interstitielle Lungenerkrankungen : Klassifikation, Differenzialdiagnostik und therapeutische Ansätze bei einer heterogenen Gruppe chronischer Lungenerkrankungen Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE Causes and Risk Factors for Absenteeism among Medical Staff in German Specialized Lung Clinics during the COVID Pandemic Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases How Informed Are German Patients with Pulmonary Sarcoidosis about Their Disease? Das virtuelle ILD-Board – Erfahrungen aus einem Pilotprojekt S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin Erratum: Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians Thoracic surgery in the non-intubated spontaneously breathing patient Clusters of comorbidities in fibrotic hypersensitivity pneumonitis „Enthusiast meets the Experienced“: Pneumo meets … Rheumatologie A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial Comparing outcomes of ILD patients managed in specialised versus non-specialised centres Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study YouTube-videos for patient education in lymphangioleiomyomatosis? Entwicklung und Fortschritt bei interstitiellen Lungenerkrankungen Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis Comorbidities in unclassifiable interstitial lung disease Entwicklung und Fortschritt bei interstitiellen Lungenerkrankungen Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany Surgical Lung Biopsy for Interstitial Lung Disease: A Two Center Propensity Score Matching Analysis Gender Differences in Health Care Workers’ Risk-Benefit Trade-Offs for COVID-19 Vaccination Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians Seltene Lungenerkrankungen Seltene Lungenerkrankungen

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Michael Kreuter (1972-)

Osteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study

National survey on the presence of multidisciplinary meetings for interstitial lung diseases (ILD-MDM) in hospitals in Germany

Nationale Umfrage zur Präsenz von interdisziplinären Fallkonferenzen bei interstitiellen Lungenerkrankungen (ILD-Boards) an Kliniken in Deutschland

Image analysis: 68Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions

Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey

Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients

Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology

SARS-CoV-2 Vaccination in Primary Humoral Immunodeficiency: Experience from a German Lung Clinic

Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort

Real-life characteristics and management of patients with fibrosing interstitial lung disease

Xolair-Dosisreduktion bei Patienten mit schwerem allergischen Asthma bronchiale in der Dauertherapie

Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional survey

Situation der Betreuung von Lungenkarzinompatienten im Hinblick auf Mindestmengenregelung und Personalmangel

Is YouTube a sufficient source of information on Sarcoidosis?

Diagnostik und Therapie der exogen-allergischen Alveolitis : S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Gesellschaft für Allergologie und klinische Immunologie e. V.

Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis

Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry

miR-Blood – a small RNA atlas of human blood components

Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory Society

YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial

Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)

Impact of systemic Sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival : : a large cohort study of the German network for systemic Sclerosis

Interstitielle Lungenerkrankungen : Klassifikation, Differenzialdiagnostik und therapeutische Ansätze bei einer heterogenen Gruppe chronischer Lungenerkrankungen

Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial

Fieber, Husten, Gliederschmerzen - ein banaler Infekt?

Interstitielle Lungenerkrankungen : Klassifikation, Differenzialdiagnostik und therapeutische Ansätze bei einer heterogenen Gruppe chronischer Lungenerkrankungen

Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE

Causes and Risk Factors for Absenteeism among Medical Staff in German Specialized Lung Clinics during the COVID Pandemic

Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases

How Informed Are German Patients with Pulmonary Sarcoidosis about Their Disease?

Das virtuelle ILD-Board – Erfahrungen aus einem Pilotprojekt

S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter

SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin

Erratum: Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V.

Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V.

Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis

Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Thoracic surgery in the non-intubated spontaneously breathing patient

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

„Enthusiast meets the Experienced“: Pneumo meets … Rheumatologie

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

Comparing outcomes of ILD patients managed in specialised versus non-specialised centres

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study

YouTube-videos for patient education in lymphangioleiomyomatosis?

Entwicklung und Fortschritt bei interstitiellen Lungenerkrankungen

Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis

Comorbidities in unclassifiable interstitial lung disease

Entwicklung und Fortschritt bei interstitiellen Lungenerkrankungen

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany

Surgical Lung Biopsy for Interstitial Lung Disease: A Two Center Propensity Score Matching Analysis

Gender Differences in Health Care Workers’ Risk-Benefit Trade-Offs for COVID-19 Vaccination

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Seltene Lungenerkrankungen

Seltene Lungenerkrankungen